Compounds > methotrexate
Page last updated: 2024-08-25

methotrexate and Devic Disease

methotrexate has been researched along with Devic Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishibashi, S; Kizawa, M; Ohkubo, T; Sanjo, N; Sato, N; Toide, N; Yokota, T1
Elsone, L; George, J; Jacob, A; Kitley, J; Leite, MI; Palace, J; Vincent, A; Waters, P; Woodhall, M1
Malhotra, K; Ramanathan, RS; Scott, T1
Chandratre, S; Halfpenny, C; Hemingway, C; Leite, MI; O'Brien, F; Palace, J; Rocha, J; Tackley, G; Wasiewski, W; Wassmer, E; Waters, P; Woodhall, M1
Beh, SC; Burns, D; Desena, A; Frohman, EM; Frohman, TC; Greenberg, B; Kildebeck, E; Narayan, R; Rowe, ES; Rowe, V; Schell, D; Whitworth, L1
Bergamaschi, R; Bogdanov, EI; Mikhaylov, IM; Moglia, A; Pichiecchio, A; Ravaglia, S1

Other Studies

6 other study(ies) available for methotrexate and Devic Disease

ArticleYear
Methotrexate-associated lymphoproliferative disorder in a patient with neuromyelitis optica spectrum disorder: An implication for pathogenesis mediated by Epstein-Barr virus.
    Journal of the neurological sciences, 2017, 08-15, Volume: 379

    Topics: Adult; Epstein-Barr Virus Infections; Female; Humans; Lymphoproliferative Disorders; Methotrexate; Neuromyelitis Optica

2017
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
    Journal of neurology, neurosurgery, and psychiatry, 2013, Volume: 84, Issue:8

    Topics: Adolescent; Adult; Aged; Antibodies; Aquaporin 4; Azathioprine; Child; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Neuromyelitis Optica; Retrospective Studies; Treatment Outcome; Young Adult

2013
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate.
    BMC neurology, 2014, Mar-15, Volume: 14

    Topics: Adult; Aged; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Neuromyelitis Optica; Retrospective Studies; Treatment Outcome

2014
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.
    Multiple sclerosis and related disorders, 2016, Volume: 7

    Topics: Adolescent; Adult; Age of Onset; Azathioprine; Black People; Disability Evaluation; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Least-Squares Analysis; Male; Methotrexate; Neuromyelitis Optica; Prospective Studies; Regression Analysis; Rituximab; Seasons; Severity of Illness Index

2016
High-dose methotrexate with leucovorin rescue: For monumentally severe CNS inflammatory syndromes.
    Journal of the neurological sciences, 2017, Jan-15, Volume: 372

    Topics: Adult; Brain; Disability Evaluation; Drug Repositioning; Drug Resistance; Female; Humans; Immunosuppressive Agents; Leucovorin; Male; Methotrexate; Middle Aged; Multiple Sclerosis; Neuromyelitis Optica; Retrospective Studies; Sjogren's Syndrome; Time Factors; Treatment Outcome

2017
Pathogenetic role of myelitis for syringomyelia.
    Clinical neurology and neurosurgery, 2007, Volume: 109, Issue:6

    Topics: Adult; Back Pain; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Multiple Sclerosis; Myelitis; Myelitis, Transverse; Neck Pain; Neurologic Examination; Neuromyelitis Optica; Paresthesia; Prednisone; Quadriplegia; Recurrence; Sarcoidosis; Spinal Cord; Syringomyelia

2007